Market Overview:
The global photosensitizer drug market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising awareness about early diagnosis and treatment of cancer, and technological advancements in the field of photodynamic therapy (PDT). The global photosensitizer drug market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into photofrin, levulan, metvix, and others. Photofrin accounted for a major share of the global photosensitizer drug market in 2017 owing to its high usage rates for PDT applications across various regions. However, levulan is expected to grow at a higher CAGR during the forecast period as it has been gaining popularity as an alternative to photofrin due to its lower toxicity levels.
Product Definition:
Photosensitizer drug is a medication that helps to make cancer cells more sensitive to radiation therapy. It is important because it can help to improve the effectiveness of radiation therapy and may help reduce the amount of radiation needed to treat cancer.
Photofrin:
Photofrin is a photosensitizer drug and is used in the treatment of cancer. It works by causing cancer cells to multiply and spread within the body, until they die. The active ingredient in photofrin, 5-ALA, has shown anti-cancer effects when tested on laboratory animals with skin tumors.
Levulan:
Levulan is a naturally occurring polymer, extracted from the fermentation of certain bacteria. It was first discovered in 1879 and patented in 1883 by the German bacteriologist, Theodor Kocher. Levulan has been used as an additive for Photodynamic Therapy (PDT) since 2000 and is approved by the U.S Food & Drug Administration (FDA) for this application as well.
Application Insights:
On the basis of application, the global photosensitizer drug market has been segmented into oncology, dermatology, ophthalmology and others. Oncology was estimated as the largest revenue-generating segment in 2017 owing to increasing prevalence of cancer across the globe. According to WHO¢â‚¬â„¢s estimates, approximately 1 in 6 deaths occur due to cancer; this amounts to around 2.5 million people every year globally. Moreover, according to data published by WHO in 2018 regarding mortality rate due to cancer worldwide; it is estimated that about 1 death occurs every 3 seconds because of this disease and more than 14 million people are diagnosed with it annually which represents a lucrative opportunity for industry players during forecast period (2018-2030).
Regional Analysis:
North America was the leading revenue contributor in 2017. The region is expected to maintain its dominance during the forecast period owing to increasing R&D activities and presence of key players in the region. In addition, rising adoption of photodynamic therapy for cancer treatment is also one of the major factors contributing toward market growth in this region.
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is primarily due to the changing lifestyles and growing population. As per the World Health Organization (WHO), there were 14 million new cases of cancer in 2012, and this number is expected to rise to 24 million by 2035. This will create a large pool of patients who will require treatment with photosensitizer drugs, thereby driving the growth of this market.
- Growing demand for targeted therapies: Cancer treatments are becoming more targeted as researchers learn more about the molecular mechanisms that drive tumor growth. Photosensitizer drugs are ideally suited for use in targeted therapies as they can specifically kill tumor cells without affecting healthy cells around them. This makes them less toxic than traditional chemotherapy drugs and hence, they are gaining popularity among patients and physicians alike.
- Technological advancements: The development of novel photosensitizers that can selectively target tumors is being driven by advances in nanotechnology and photodynamic therapy (PDT). PDT involves using light energy to activate a photosensitizer drug which then kills tumor cells within minutes or hours depending on its type .This makes PDT a very promising treatment option for many types of cancers including those that are resistant to traditional chemotherapy treatments .
Scope Of The Report
Report Attributes
Report Details
Report Title
Photosensitizer Drug Market Research Report
By Type
Photofrin, Levulan, Metvix, Others
By Application
Oncology, Dermatology, Ophthalmology
By Companies
Sanofi, DUSA Pharmaceuticals, Bausch Health, Beiersdorf, Soligenix, Theralase Technologies, Quest Pharmatech, Galderma, Biofrontera
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Photosensitizer Drug Market Report Segments:
The global Photosensitizer Drug market is segmented on the basis of:
Types
Photofrin, Levulan, Metvix, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Dermatology, Ophthalmology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- DUSA Pharmaceuticals
- Bausch Health
- Beiersdorf
- Soligenix
- Theralase Technologies
- Quest Pharmatech
- Galderma
- Biofrontera
Highlights of The Photosensitizer Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Photofrin
- Levulan
- Metvix
- Others
- By Application:
- Oncology
- Dermatology
- Ophthalmology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Photosensitizer Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Photosensitizer drugs are medications that increase the sensitivity of the skin to sunlight. This can be useful in treating conditions such as psoriasis, eczema, and sunburn.
Some of the key players operating in the photosensitizer drug market are Sanofi, DUSA Pharmaceuticals, Bausch Health, Beiersdorf, Soligenix, Theralase Technologies, Quest Pharmatech, Galderma, Biofrontera.
The photosensitizer drug market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Photosensitizer Drug Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Photosensitizer Drug Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Photosensitizer Drug Market - Supply Chain
4.5. Global Photosensitizer Drug Market Forecast
4.5.1. Photosensitizer Drug Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Photosensitizer Drug Market Size (000 Units) and Y-o-Y Growth
4.5.3. Photosensitizer Drug Market Absolute $ Opportunity
5. Global Photosensitizer Drug Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Photosensitizer Drug Market Size and Volume Forecast by Type
5.3.1. Photofrin
5.3.2. Levulan
5.3.3. Metvix
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Photosensitizer Drug Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Photosensitizer Drug Market Size and Volume Forecast by Application
6.3.1. Oncology
6.3.2. Dermatology
6.3.3. Ophthalmology
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Photosensitizer Drug Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Photosensitizer Drug Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Photosensitizer Drug Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Photosensitizer Drug Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Photosensitizer Drug Demand Share Forecast, 2019-2026
9. North America Photosensitizer Drug Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Photosensitizer Drug Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Photosensitizer Drug Market Size and Volume Forecast by Application
9.4.1. Oncology
9.4.2. Dermatology
9.4.3. Ophthalmology
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Photosensitizer Drug Market Size and Volume Forecast by Type
9.7.1. Photofrin
9.7.2. Levulan
9.7.3. Metvix
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Photosensitizer Drug Demand Share Forecast, 2019-2026
10. Latin America Photosensitizer Drug Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Photosensitizer Drug Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Photosensitizer Drug Market Size and Volume Forecast by Application
10.4.1. Oncology
10.4.2. Dermatology
10.4.3. Ophthalmology
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Photosensitizer Drug Market Size and Volume Forecast by Type
10.7.1. Photofrin
10.7.2. Levulan
10.7.3. Metvix
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Photosensitizer Drug Demand Share Forecast, 2019-2026
11. Europe Photosensitizer Drug Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Photosensitizer Drug Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Photosensitizer Drug Market Size and Volume Forecast by Application
11.4.1. Oncology
11.4.2. Dermatology
11.4.3. Ophthalmology
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Photosensitizer Drug Market Size and Volume Forecast by Type
11.7.1. Photofrin
11.7.2. Levulan
11.7.3. Metvix
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projectins by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Photosensitizer Drug Demand Share, 2019-2026
12. Asia Pacific Photosensitizer Drug Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Photosensitizer Drug Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Photosensitizer Drug Market Size and Volume Forecast by Application
12.4.1. Oncology
12.4.2. Dermatology
12.4.3. Ophthalmology
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Photosensitizer Drug Market Size and Volume Forecast by Type
12.7.1. Photofrin
12.7.2. Levulan
12.7.3. Metvix
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Photosensitizer Drug Demand Share, 2019-2026
13. Middle East & Africa Photosensitizer Drug Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Photosensitizer Drug Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Photosensitizer Drug Market Size and Volume Forecast by Application
13.4.1. Oncology
13.4.2. Dermatology
13.4.3. Ophthalmology
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Photosensitizer Drug Market Size and Volume Forecast by Type
13.7.1. Photofrin
13.7.2. Levulan
13.7.3. Metvix
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Photosensitizer Drug Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Photosensitizer Drug Market: Market Share Analysis
14.2. Photosensitizer Drug Distributors and Customers
14.3. Photosensitizer Drug Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sanofi
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. DUSA Pharmaceuticals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bausch Health
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Beiersdorf
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Soligenix
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Theralase Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Quest Pharmatech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Galderma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biofrontera
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
